Compounded Pyrimethamine: 'Personalized Medicine' Or 'Unapproved Drug'?
Executive Summary
Responding to the Express Scripts' deal to promote use of a compounded alternative to its drug, Turing says physicians shouldn't prescribe the compound, since it is an unapproved and unsafe drug. But the compounder, Imprimis, says each prescription is custom-made, making it a "personalized medicine."
You may also be interested in...
Compounding For Lower Prices Not PBMs’ New ‘Game Plan,’ Lawmakers Told
Pharmacy benefit manager trade group chief Mark Merritt says PBMs are not poised to broadly promote compounded drugs as cheaper alternatives to off-patent drugs with no generic competition.
Express Scripts Turns To Compounding To Fight High-Priced Off-Patent Drugs
Pharmacy benefit manager's anti-Daraprim effort signals new direction in pricing battles, but the strategy can only be used in limited circumstances.
FDA Steps Into Makena Pricing Dispute In The Name Of "Access"
FDA is citing patient access as the reason behind its unusual decision to insert itself in the middle of a pricing debate involving KV Pharmaceuticals’ pre-term delivery drug Makena.